FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine specifically to use of sodium cobalt polygalacturonate (PGNaCo) as an agent with cytotoxic activity against A549 lung carcinoma and MCF-7 breast adenocarcinoma.
EFFECT: present invention provides an implementation of the assignment.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTITUMOR AGENTS BASED ON MACRO- AND MICROELEMENT-CONTAINING POLYGALACTURONATES (OPTIONS) | 2022 |
|
RU2792613C1 |
| NEW STERICALLY HINDERED PHENOLS CONTAINING BENZOFUROXAN FRAGMENTS WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2796810C1 |
| BROMINE-CONTAINING STERICALLY HINDERED PHENOLS WITH ANTICANCER ACTIVITY | 2023 |
|
RU2822270C1 |
| 24-DIBROM-4-OXO-2-CYANO-3,23-DINOLUP-28-OIC ACID METHYL ETER WITH CYTOTOXIC ACTIVITY | 2022 |
|
RU2784317C1 |
| MIXED-LIGAND COMPLEXES OF COPPER (II) WITH 1H-TETRAZOLE-5-ACETIC ACID AND OLIGOPYRIDINE DERIVATIVES, EXHIBITING CYTOTOXIC ACTIVITY | 2023 |
|
RU2818953C1 |
| PHOSPHONIUM SALTS BASED ON ALANTOLACTONE, HAVING ANTI-TUMOUR ACTIVITY, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2818095C1 |
| METHYL ESTERS 3-METHYL-3-OXO-1-CYANO-2,3-SECO-2-NORLUP-20(29)-ENE-30-AL-28 AND 3-BROMETHYLENE-3-OXO-1-CYANO -2,3-SECO-2-NORLUP-20(29)-ENE-30-AL-28 ACIDS WHICH EXHIBIT CYTOTOXIC ACTIVITY | 2016 |
|
RU2632002C1 |
| ANTICANCER DRUG BASED ON NICLOSAMIDE | 2016 |
|
RU2617049C1 |
| ANTITUMOR COMPOSITION OF DOXORUBICIN WITH ATP INHIBITOR-DEPENDENT REVERSE CELL TRANSPORTER | 2018 |
|
RU2680834C1 |
| PHOSPHONIUM SALTS BASED ON BETULINIC ACID, WITH CYTOTOXIC ACTIVITY RELATED TO PROSTATIC ACINOUS CARCINOMA | 2018 |
|
RU2665922C1 |
